Overview

• The U.S. Court of Appeals upheld a decision invalidating three AliveCor patents related to EKG technology used in the Apple Watch.
• This ruling effectively nullifies the International Trade Commission's earlier recommendation for an Apple Watch import ban.
• AliveCor originally accused Apple of infringing on its patents in 2021, but the patents were later deemed unpatentable by the Patent Trial and Appeal Board (PTAB).
• AliveCor expressed disappointment with the decision and stated its intention to explore further legal options to defend its intellectual property claims.
• Apple welcomed the ruling, emphasizing its commitment to developing innovative health and wellness features for its products.